Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Oct 22, 2026

Press release

Vespexx Recognized as Finalist for the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH

SEOUL, South Korea, Oct. 22, 2026 /PRNewswire/ -- Vespexx Inc., an AI-driven femtech company, today announced it has been named a Finalist for the Digital Health Hub Foundation's Digital Health & AI Awards 2026, held at HLTH. Competing in the Rising Star track under the Women's & Family Health category, Vespexx advanced from the Quarterfinalist stage announced earlier this fall, standing out among more than 1,300 submissions.Continue Reading The Digital Health & AI A
Press release cover image

Oct 22, 2026

Press release

Redesign Health and ARC Global Merge to Help Health Systems Shape the Future of Healthcare From Within

Redesign Health and Sheba Medical Center's ARC Global also to acquire AVIA, with the three organizations bringing together more than 100 health systems and the technology, talent and capital to turn frontline ideas into products and companies that scale worldwideDr. Stephen Klasko named chairman of the board; Prof. Eyal Zimlichman, founder and president of ARC Global, joins Redesign Health as vice chairmanNEW YORK, Oct. 22, 2026 /PRNewswire/ -- Redesign Health, a global venture and applied techn
Press release cover image

Oct 22, 2026

Press release

Eko Health Launches CORE 300™ to Bring AI-Enabled Stethoscopes to Every Healthcare Professional

Company announces FDA 510(k) clearance of the device for use in pediatric and adult patients. CORE 300 is the first stethoscope to integrate traditional and digital listening modes directly into a single chestpiece and delivers FDA-cleared AI for structural murmur detection.SAN FRANCISCO, Oct. 22, 2026 /PRNewswire/ -- Eko Health, a leader in clinical AI for the early detection of heart and lung disease, today announced the FDA clearance and launch of CORE 300, a new AI enabled stethoscope that c
Press release cover image

Oct 22, 2026

Press release

Ignite Proteomics Enters Breast Cancer Research Collaboration with Leading Cancer Center

GOLDEN, Colo., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ignite Proteomics, Inc. (“Ignite” or the “Company”), a precision oncology company focused on functional proteomics, today announced it is collaborating with Memorial Sloan Kettering Cancer Center (“MSK”) to study protein signaling patterns associated with treatment response and resistance in advanced breast cancer. Ignite will apply its reverse phase protein array (“RPPA”)-based proteomic test to tumor samples. The effort will evaluate proteomic
A prescription pad and pill bottle cap on a pharmacy counter in low light.

Oct 22, 2026

FDA recognizes standalone software's role in improving drug therapy

The FDA has taken a significant step in recognizing the role of standalone software in enhancing drug therapy through new guidance for prescription drug use-related software (PDURS).This guidance establishes a framework for the integration of digital health tools, such as dosage reminders and health coaching applications, into the drug prescribing process. By requiring that these standalone apps be included on prescribing labels when they demonstrate clinical benefits or are essential for safe m
Press release cover image

Oct 22, 2026

Press release

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Two strong partners aim to accelerate AI-enabled clinical developmentBuilding a foundation for Digital Patient Twins to bring safe and effective therapies to patients soonerPotential co-development of projects in Animal Health and business functions Cologne, Germany - Boehringer Ingelheim and Microsoft today announced a strategic collaboration that aims to bring safe and effective therapies to patients sooner fueled by AI. The collaboration will focus on jointly investigating the potential of Di
A minimalist representation of a pill capsule and an AI brain icon, illustrating biotech and AI integration.

Oct 22, 2026

OpenAI acquires biotech startup Orchestra Bio

OpenAI has made a strategic move by acquiring Orchestra Bio, a startup focused on AI solutions for biotechnology, enhancing its capabilities in life sciences research.This acquisition, announced on October 20, marks OpenAI's commitment to expanding its suite of tools tailored for the biotechnology sector. While the financial details remain undisclosed, Orchestra Bio has previously garnered around $20 million in funding from notable investors such as Andreessen Horowitz and Atria.Orchestra Bio sp
Press release cover image

Oct 22, 2026

Press release

Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum Builds

A multi-year MSA for EHR optimization and healthcare cybersecurity, MEDITECH-based Rural Health Transformation advisory work in three states, in addition to a new multi-year engagement to support a healthcare business unit's global technology centerPLEASANTON, Calif., Oct. 22, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced that its wholly owned, AI-led subsidiary, Purpose Health, Inc., has signed a series of multi-year agreements. Purpose
Press release cover image

Oct 22, 2026

Press release

Tairex Launches Multi-Agent AI System to Transform Clinical Collaboration and Decision Support

BEIJING, Oct. 22, 2026 /PRNewswire/ -- On 21 October, Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, unveiled the Multidisciplinary Human-Agent Collaboration (MHAC) Ecosystem for Agent Hospital, designed to enable specialized AI agents to work alongside physicians on clinical cases.01. From Virtual Training to Real-World CollaborationIn a simulated environment populated by millions of highly realistic AI patients, an
Press release cover image

Oct 22, 2026

Press release

Genedata Expands AI Discovery Workflows with NVIDIA BioNeMo Open Models, Including the New RFD4-Proteina Release

Bringing next-generation binder design models into production discovery BASEL, Switzerland, Oct. 22, 2026 /PRNewswire/ -- Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the addition of the new RFD4-Proteina binder design model into Genedata's AI-enabled discovery workflows, following the model's introduction at NVIDIA GTC Berlin. As an early ecosystem partner, Genedata is among the first companies to make RFD4
A chemical compound in a glass vial on a lab bench with shelves of glassware behind it.

Oct 22, 2026

Innovating at Speed in an Underrated Drug-Making Process

Novartis is revolutionizing chemical manufacturing controls (CMC) with a cutting-edge self-service platform developed in collaboration with Genedata, utilizing AI to enhance operational efficiency and reduce submission timelines.The innovative platform, known internally as SPINE Explorer, facilitates real-time monitoring and in silico experimentation in drug manufacturing. Novartis's approach highlights the often-overlooked importance of CMC, which is crucial for ensuring drug quality and safety
Press release cover image

Oct 22, 2026

Press release

Asimov Announces Adoption of Its AI-Driven Cell Line Development Platform by LG Chem

Asimov’s CHO Edge System, including the recently announced Chrysalis transposase and Kernel, Asimov’s AI-driven genetic design software, will support LG Chem’s biologics cell line development activitiesBOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a licensing agreement with South Korea-based LG Chem, a leading global chemical company with a diversified business portfolio spanning